These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

457 related items for PubMed ID: 7041132

  • 1. The human alternative complement pathway: biology and immunopathology of activation and regulation.
    Kazatchkine MD, Nydegger UE.
    Prog Allergy; 1982; 30():193-234. PubMed ID: 7041132
    [No Abstract] [Full Text] [Related]

  • 2. Current concepts in immunology: the alternative pathway of complement--a system for host resistance to microbial infection.
    Fearon DT, Austen KF.
    N Engl J Med; 1980 Jul 31; 303(5):259-63. PubMed ID: 6900901
    [No Abstract] [Full Text] [Related]

  • 3. The role of immunoglobulins in alternative pathway activation by zymosan. II. The effect of IgG on the kinetics of the alternative pathway.
    Schenkein HA, Ruddy S.
    J Immunol; 1981 Jan 31; 126(1):11-5. PubMed ID: 6905857
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Proteases in complement system (author's transl)].
    Nagasawa S.
    Tanpakushitsu Kakusan Koso; 1980 Jan 31; 25(6):531-46. PubMed ID: 7010425
    [No Abstract] [Full Text] [Related]

  • 7. Alterations in C3 activation and binding caused by phosphorylation by a casein kinase released from activated human platelets.
    Ekdahl KN, Nilsson B.
    J Immunol; 1999 Jun 15; 162(12):7426-33. PubMed ID: 10358196
    [Abstract] [Full Text] [Related]

  • 8. Effect of nephritic factor on C3 and on the terminal pathway of complement in vivo and in vitro.
    Mollnes TE, Ng YC, Peters DK, Lea T, Tschopp J, Harboe M.
    Clin Exp Immunol; 1986 Jul 15; 65(1):73-9. PubMed ID: 3641694
    [Abstract] [Full Text] [Related]

  • 9. [Complement: mechanisms of activation, functions, analysis].
    Dessaint JP, Wattre P, Santoro F, Capron A.
    Lille Med; 1979 Jul 15; 24(7):551-8. PubMed ID: 397392
    [No Abstract] [Full Text] [Related]

  • 10. [Progress in the knowledge of complement. I. Structure, activation and control of the complement system].
    Lesavre P, Leibowitch J.
    Nouv Presse Med; 1979 Jun 30; 8(29):2385-7. PubMed ID: 493022
    [No Abstract] [Full Text] [Related]

  • 11. Alternative pathway complement activation in rheumatoid arthritis.
    El-Ghobarey A, Whaley K.
    J Rheumatol; 1980 Jun 30; 7(4):453-60. PubMed ID: 6158571
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Progress in the immunochemical studies of complement--including the establishment of nomenclature of complement proteins].
    Inai S.
    Nihon Rinsho; 1979 May 10; 37(5):923-9. PubMed ID: 381722
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Alternative complement pathway (author's transl)].
    Kazatchkine M, Nydegger U, Fearon DT.
    Nouv Presse Med; 1979 Jun 09; 8(26):2187-94. PubMed ID: 382108
    [Abstract] [Full Text] [Related]

  • 19. How do complement components and fragments affect cellular immunological function?
    Gelfand JA.
    J Trauma; 1984 Sep 09; 24(9 Suppl):S118-24. PubMed ID: 6332921
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.